🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Treatment Gaining Traction Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are urged to message these profiles privately for source information, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and assertions of next-day UK delivery. Vendors market the substance there before directing buyers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Express Concerns

However, doctors and pharmacists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in users administering products of uncertain source.

Some experts stated the popularity for the experimental drug could be connected to the increasing price of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.

Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate pharmaceutical, marketing, and customer laws, risking fines, legal action or prison.

Service Response and Material Elimination

Based on TikTok, the service has removed problematic material and prohibited associated hashtags and search suggestions. The organization said it was committed to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Online Trading Activities

Investigations also found groups with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of members, filled with images of slimming results, positive reviews and detailed instructions for preparing or injecting at residence.

Within minutes of joining one community, a seller posted contact information, where the majority of purchases occur. The vendor provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about weight, medical conditions or previous experience.

Item Information and Pricing

Within these communities, messages display black plastic packages with postal service stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use injectors usually sold at £160 for 20mg. When asked how long a pen should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for Telegram said it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering materials they can’t verify. Although the science behind retatrutide is valid, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are using online platforms. But fake treatments are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has already encountered patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A representative from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose users to possibly serious medical dangers”.